The DOI matches its Crossref record; 168 of the 168 references it cites were found in a registry or an index.
Prostate cancer epidemiology
Open accessAbstract
Prostate cancer is the most common non-skin cancer among men in most western populations, and it is the second leading cause of cancer death among U.S. men. Despite its high morbidity, the etiology of prostate cancer remains largely unknown. Advancing age, race, and a family history of prostate cancer are the only established risk factors. Many putative risk factors, including androgens, diet, physical activity, sexual factors, inflammation, and obesity, have been implicated, but their roles in prostate cancer etiology remain unclear. It is estimated that as much as 42% of the risk of prostate cancer may be accounted for by genetic influences, including individual and combined effects of rare, highly penetrant genes, more common weakly penetrant genes, and genes acting in concert with each other. Numerous genetic variants in the androgen biosynthesis/metabolism, carcinogen metabolism, DNA repair, and chronic inflammation pathways, have been explored, but the results are largely inconclusive. The pathogenesis of prostate cancer likely involves interplay between environmental and genetic factors. To unravel these complex relationships, large well-designed interdisciplinary epidemiologic studies are needed. With newly available molecular tools, a new generation of large-scale multidisciplinary population-based studies is beginning to investigate gene-gene and gene-environment interactions. Results of these studies may lead to better detection, treatment, and, ultimately, prevention of prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,403
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Jemal, A., Murray, T., Ward, E., Samuels, A., Tiwari, R. C., Ghafoor, A., Feuer, E. J., & Thun, M. J. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.1.10 · Cited by 4,186
Lichtenstein, P., Holm, N. V., Verkasalo, P. K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A., & Hemminki, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007133430201 · Cited by 4,114
Huggins, C., & Hodges, C. V. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64820-3 · Cited by 3,855
Parkin, D. M., Pisani, P., & Ferlay, J. (1999) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.33 · Cited by 3,376
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,424
The insulin-like growth factor system and cancer
LeRoith, D., & Roberts, C. T. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00159-9 · Cited by 1,124
Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County
Shimizu, H., Ross, R., Bernstein, L., Yatani, R., Henderson, B., & Mack, T. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.210 · Cited by 890
The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
Giovannucci, E., Stampfer, M. J., Krithivas, K., Brown, M., Brufsky, A., Talcott, J., Hennekens, C. H., & Kantoff, P. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3320 · Cited by 873
Proliferative Inflammatory Atrophy of the Prostate
De Marzo, A. M., Marchi, V. L., Epstein, J. I., & Nelson, W. G. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65517-4 · Cited by 872
Aspirin use and risk of fatal cancer.
Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., & Heath, C. W. (1993) · PubMed · Cited by 870
International trends and patterns of prostate cancer incidence and mortality
Hsing, A. W., Tsao, L., & Devesa, S. S. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000101)85:1<60::aid-ijc11>3.0.co;2-b · Cited by 846
Self-citationProspective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782
The Role of Increasing Detection in the Rising Incidence of Prostate Cancer
Potosky, A. L. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520310046028 · Cited by 674
Hereditary Prostate Cancer: Epidemiologic and Clinical Features
Carter, B. S., Bova, G. S., Beaty, T. H., Steinberg, G. D., Childs, B., Isaacs, W. B., & Walsh, P. C. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35617-3 · Cited by 612
Ingles, S. A., Ross, R. K., Yu, M. C., Haile, R. W., Irvine, R. A., La Pera, G., & Coetzee, G. A. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.2.166 · Cited by 583
A candidate prostate cancer susceptibility gene at chromosome 17p
Tavtigian, S. V., Simard, J., Teng, D. H. F., Abtin, V., Baumgard, M., Beck, A., Camp, N. J., Carillo, A. R., Chen, Y., Dayananth, P., et al. (2001) · Nature Genetics · doi:10.1038/84808 · Cited by 557
RESPONSE Re: Markers of DNA Repair and Susceptibility to Cancer in Humans: an Epidemiologic Review
Berwick, M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1537 · Cited by 545
Pathological and molecular aspects of prostate cancer
DeMarzo, A. M., Nelson, W. G., Isaacs, W. B., & Epstein, J. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12779-1 · Cited by 472
Amirimani, B., Walker, A. H., Weber, B. L., & Rebbeck, T. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1588 · Cited by 465
Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.
Stanford, J. L., Just, J. J., Gibbs, M., Wicklund, K. G., Neal, C. L., Blumenstein, B. A., & Ostrander, E. A. (1997) · PubMed · Cited by 447
Physical activity and cancer prevention–data from epidemiologic studies
LEE, I.-M. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000093620.27893.23 · Cited by 436
Chan, J. M. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.14.1099 · Cited by 433
Use of Agricultural Pesticides and Prostate Cancer Risk in the Agricultural Health Study Cohort
Alavanja, M. C. R. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg040 · Cited by 425
Stram, D. O., Haiman, C. A., Hirschhorn, J. N., Altshuler, D., Kolonel, L. N., Henderson, B. E., & Pike, M. C. (2003) · Human Heredity · doi:10.1159/000071807 · Cited by 406
The complex genetic epidemiology of prostate cancer
Schaid, D. J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh072 · Cited by 368
Risch, N., & Teng, J. (1998) · Genome Research · doi:10.1101/gr.8.12.1273 · Cited by 366
Modification of Clinical Presentation of Prostate Tumors by a Novel Genetic Variant in CYP3A4
Rebbeck, T. R., Jaffe, J. M., Walker, A. H., Wein, A. J., & Malkowicz, S. B. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.16.1225 · Cited by 360
NOBLE, R. L. (1977) · PubMed · Cited by 347
Influence of cytokine gene polymorphisms on the development of prostate cancer.
McCarron, S. L., Edwards, S. M., Evans, P. R., Gibbs, R., Dearnaley, D. P., Dowe, A., Southgate, C., Easton, D. F., Eeles, R. A., & Howell, W. M. (2002) · PubMed · Cited by 336
Allium Vegetables and Risk of Prostate Cancer: A Population-Based Study
Hsing, A. W. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.21.1648 · Cited by 321
Self-citationMakridakis, N. M., Ross, R. K., Pike, M. C., Crocitto, L. E., Kolonel, L. N., Pearce, C. L., Henderson, B. E., & Reichardt, J. K. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11282-5 · Cited by 314
Brassica Vegetables and Prostate Cancer Risk: A Review of the Epidemiological Evidence
Kristal, A. R., & Lampe, J. W. (2002) · Nutrition and Cancer · doi:10.1207/s15327914nc421_1 · Cited by 311
Hsing, A. W., Gao, Y., Wu, G., Wang, X., Deng, J., Chen, Y., Sesterhenn, I. A., Mostofi, F. K., Bénichou, J., & Chang, C. (2000) · PubMed · Cited by 311
Self-citationZinc Supplement Use and Risk of Prostate Cancer
Leitzmann, M. F., Stampfer, M. J., Wu, K., Colditz, G. A., Willett, W. C., & Giovannucci, E. L. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.13.1004 · Cited by 307
RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases
Casey, G., Neville, P. J., Plummer, S. J., Xiang, Y., Krumroy, L. M., Klein, E. A., Catalona, W. J., Nupponen, N., Carpten, J. D., Trent, J. M., et al. (2002) · Nature Genetics · doi:10.1038/ng1021 · Cited by 305
Prostate Cancer Risk and Serum Levels of Insulin and Leptin: a Population-Based Study
Hsing, A. W., Chua, S., Gao, Y.-T., Gentzschein, E., Chang, L., Deng, J., & Stanczyk, F. Z. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.10.783 · Cited by 298
Self-citationTrends and Patterns of Prostate Cancer: What Do They Suggest?
Hsing, A. W., & Devesa, S. S. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000792 · Cited by 292
Self-citationTerry, P. D., Rohan, T. E., & Wolk, A. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.3.532 · Cited by 285
Fatty fish consumption and risk of prostate cancer
Terry, P., Lichtenstein, P., Feychting, M., Ahlbom, A., & Wolk, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04889-3 · Cited by 284
A prospective study of intake of fish and marine fatty acids and prostate cancer.
Bälter, K. A., Michaud, D. S., Rimm, E. B., Leitzmann, M. F., Stampfer, M. J., Willett, W. C., & Giovannucci, E. L. (2003) · PubMed · Cited by 279
Silverio, F. D., Gentile, V., Matteis, A. D., Mariotti, G., Voria, G., Pastore, A. L., & Sciarra, A. (2003) · European Urology · doi:10.1016/s0302-2838(02)00548-1 · Cited by 277
Meta-Analysis of Measures of Sexual Activity and Prostate Cancer
Dennis, L. K., & Dawson, D. V. (2002) · Epidemiology · doi:10.1097/00001648-200201000-00012 · Cited by 274
Androgen Metabolism and Prostate Cancer: Establishing a Model of Genetic Susceptibility
Ross, R. K., Coetzee, G. A., Pearce, C. L., Reichardt, J. K. V., Bretsky, P., Kolonel, L. N., Henderson, B. E., Lander, E., Altshuler, D., & Daley, G. (1999) · European Urology · doi:10.1159/000019909 · Cited by 264
SELECT: THE NEXT PROSTATE CANCER PREVENTION TRIAL
KLEIN, E. A., THOMPSON, I. M., LIPPMAN, S. M., GOODMAN, P. J., ALBANES, D., TAYLOR, P. R., & COLTMAN, C. (2001) · Journal of Urology · doi:10.1016/s0022-5347(05)65759-x · Cited by 257
Dietary Fat and Prostate Cancer: Current Status
Kolonel, L. N., Nomura, A. M. Y., & Cooney, R. V. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.5.414 · Cited by 251
Platz, E. A., Leitzmann, M. F., Rifai, N., Kantoff, P. W., Chen, Y.-C., Stampfer, M. J., Willett, W. C., & Giovannucci, E. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0371 · Cited by 245
Epidemiology of Inflammation and Prostate Cancer
PLATZ, E. A., & De MARZO, A. M. (2004) · Journal of Urology · doi:10.1097/01.ju.0000108131.43160.77 · Cited by 243
COOK, L. S., GOLDOFT, M., SCHWARTZ, S. M., & WEISS, N. S. (1999) · Journal of Urology · doi:10.1016/s0022-5347(01)62086-x · Cited by 241
Rökman, A., Ikonen, T., Seppälä, E. H., Nupponen, N., Autio, V., Mononen, N., Bailey-Wilson, J., Trent, J., Carpten, J., Matikainen, M. P., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/340450 · Cited by 238
Diet: Fat, Meat, and Prostate Cancer
Kolonel, L. N. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000798 · Cited by 237
Li, H., Kantoff, P. W., Giovannucci, E., Leitzmann, M. F., Gaziano, J. M., Stampfer, M. J., & Ma, J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3535 · Cited by 236
Hormones and Prostate Cancer: What's Next?
Hsing, A. W. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000795 · Cited by 216
Self-citationMa, J., Stampfer, M. J., Gann, P. H., et al. (1998) · PubMed · Cited by 214
Endogenous sex hormones and prostate cancer: a quantitative review of prospective studies
Eaton, N. E., Reeves, G. K., Appleby, P. N., & Key, T. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690445 · Cited by 213
Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2)
Lunn, R. M., Bell, D. A., Mohler, J. L., & Taylor, J. A. (1999) · Carcinogenesis · doi:10.1093/carcin/20.9.1727 · Cited by 209
Hormones and prostate cancer: Current perspectives and future directions
Hsing, A. W., Reichardt, J. K. V., & Stanczyk, F. Z. (2002) · The Prostate · doi:10.1002/pros.10108 · Cited by 208
Self-citationGenetics of Prostate Cancer: Too Many Loci, Too Few Genes
Ostrander, E. A., & Stanford, J. L. (2000) · The American Journal of Human Genetics · doi:10.1086/316916 · Cited by 198
Paris, P. L., Kupelian, P. A., Hall, J., et al. (1999) · PubMed · Cited by 189
Latil, A. G., Azzouzi, R., Cancel, G. S., Guillaume, E. C., Cochan-Priollet, B., Berthon, P. L., & Cussenot, O. (2001) · Cancer · doi:10.1002/1097-0142(20010901)92:5<1130::aid-cncr1430>3.0.co;2-b · Cited by 187
Stattin, P., Lumme, S., Tenkanen, L., Alfthan, H., Jellum, E., Hallmans, G., Thoresen, S., Hakulinen, T., Luostarinen, T., Lehtinen, M., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.11572 · Cited by 187
Heterocyclic Amine Content of Cooked Meat and Risk of Prostate Cancer
Norrish, A. E., Ferguson, L. R., Knize, M. G., Felton, J. S., Sharpe, S. J., & Jackson, R. T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.23.2038 · Cited by 178
Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis
Mahmud, S., Franco, E., & Aprikian, A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601416 · Cited by 171
Associations between hOGG1 sequence variants and prostate cancer susceptibility.
Xu, J., Zheng, S. L., Turner, A. R., et al. (2002) · PubMed · Cited by 170
Nelson, J. E., & Harris, R. E. (2000) · Oncology Reports · doi:10.3892/or.7.1.169 · Cited by 165
Modugno, F., Weissfeld, J. L., Trump, D. L., Zmuda, J. M., Shea, P., Cauley, J. A., & Ferrell, R. E. (2001) · PubMed · Cited by 161
Body size and prostate cancer: a population-based case-control study in China.
Hsing, A. W., Deng, J., Sesterhenn, I. A., Mostofi, F. K., Stanczyk, F. Z., Bénichou, J., Xie, T., & Gao, Y.-T. (2000) · PubMed · Cited by 159
Self-citationAssociation of HPC2/ELAC2 Genotypes and Prostate Cancer
Rebbeck, T. R., Walker, A. H., Zeigler-Johnson, C., Weisburg, S., Martin, A.-M., Nathanson, K. L., Wein, A. J., & Malkowicz, S. B. (2000) · The American Journal of Human Genetics · doi:10.1086/303096 · Cited by 159
Rise in prostatic Cancer Incidence Associated With Increased Use of Transurethral Resection
Potosky, A. L., Kessier, L., Gridley, G., et al. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.20.1624 · Cited by 156
Stattin, P. E., Rinaldi, S., Biessy, C., Stenman, U., Hallmans, G., & Kaaks, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.105 · Cited by 155
Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival
Edwards, S. M., Badzioch, M. D., Minter, R., Hamoudi, R., Collins, N., Ardern-Jones, A. T., Dowe, A., Osborne, S. A., Kelly, J. A., Shearer, R. J., et al. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19991022)84:5<458::aid-ijc2>3.0.co;2-y · Cited by 152
A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort
Haiman, C. A., Stram, D. O., Pike, M. C., Kolonel, L. N., Burtt, N. P., Altshuler, D., Hirschhorn, J., & Henderson, B. E. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg294 · Cited by 150
Correa-Cerro, L. S., Wöhr, G., Häussler, J., Berthon, P., Drelon, E., Mangin, P., Fournier, G., Cussenot, O., Kraus, P., Just, W., et al. (1999) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200298 · Cited by 146
Diet: Dairy Products, Calcium, and Vitamin D and Risk of Prostate Cancer
Chan, J. M., & Giovannucci, E. L. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000800 · Cited by 140
Stanford, J. L., & Ostrander, E. A. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000789 · Cited by 138
Hickey, K., Do, K.-A., & Green, A. C. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000776 · Cited by 137
Zeegers, M. P., Kiemeney, L. A. L. M., Nieder, A. M., & D, H. O. M. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.1765.13.11 · Cited by 132
DNA Repair Gene XRCC1 and XPD Polymorphisms and Risk of Prostate Cancer
Rybicki, B. A., Conti, D. V., Moreira, A. A., Cicek, M. S., Casey, G., & Witte, J. S. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-03-0053 · Cited by 132
Ejaculation Frequency and Subsequent Risk of Prostate Cancer
Leitzmann, M. F. (2004) · JAMA · doi:10.1001/jama.291.13.1578 · Cited by 132
Ntais, C., Polycarpou, A., & Ioannidis, J. P. A. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.176.14.1 · Cited by 123
Zeigler-Johnson, C. M., Friebel, T. M., Walker, A. H., Wang, Y., Spangler, E., Panossian, S., Patacsil‐Coomes, M., Aplenc, R., Wein, A. J., Malkowicz, S. B., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1651 · Cited by 123
Analysis of the RNASEL Gene in Familial and Sporadic Prostate Cancer
Wang, L., McDonnell, S. K., Elkins, D. A., Slager, S. L., Christensen, E., Marks, A. F., Cunningham, J. M., Peterson, B. J., Jacobsen, S. J., Cerhan, J. R., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/341281 · Cited by 121
Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility
Tubaro, A. (1999) · Current Opinion in Urology · doi:10.1097/00042307-199911000-00022 · Cited by 116
Hsing, A. W., Chen, C., Chokkalingam, A. P., Gao, Y., Dightman, D. A., Nguyen, H. T., Deng, J., Cheng, J., Ia, S., Mostofi, F. K., et al. (2001) · PubMed · Cited by 116
Self-citationMohr, B. A., Feldman, H. A., Kalish, L. A., Longcope, C., & McKinlay, J. B. (2001) · Urology · doi:10.1016/s0090-4295(00)01116-x · Cited by 113
Selenium: Epidemiology and Basic Science
Klein, E. A. (2004) · The Journal of Urology · doi:10.1097/01.ju.0000107837.66277.e9 · Cited by 113
Xu, J., Zheng, S. L., Carpten, J. D., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/319513 · Cited by 110
Diet and urinary steroids in black and white North American men and black South African men.
Hill, P., Wynder, E. L., Garbaczewski, L., Garnes, H. A., & Walker, A. R. P. (1979) · PubMed · Cited by 109
Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis.
Ntais, C., Polycarpou, A., & Ioannidis, J. P. A. (2003) · PubMed · Cited by 108
The androgen receptor gene GGN microsatellite and prostate cancer risk.
Platz, E. A., Giovannucci, E. L., Dahl, D. M., Krithivas, K., Hennekens, C. H., Brown, M. A., Stampfer, M. J., & Kantoff, P. W. (1998) · PubMed · Cited by 107
Chen, C., Weiss, N. S., Stanczyk, F. Z., Lewis, S. K., diTommaso, D., Etzioni, R., Barnett, M. J., & Goodman, G. E. (2003) · PubMed · Cited by 106
COX-2 gene promoter haplotypes and prostate cancer risk
Panguluri, R. K. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh100 · Cited by 105
Xu, J., Zheng, S. L., Komiya, A., Mychaleckyj, J. C., Isaacs, S. D., Chang, B., Turner, A. R., Ewing, C. M., Wiley, K. E., Hawkins, G. A., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/345802 · Cited by 101
Nam, R. K., Toi, A., Vesprini, D., Ho, M., Chu, W., Harvie, S., Sweet, J., Trachtenberg, J., Jewett, M. A. S., & Narod, S. A. (2001) · Urology · doi:10.1016/s0090-4295(00)00928-6 · Cited by 100
Features of the metabolic syndrome and prostate cancer in African‐American men
Beebe‐Dimmer, J., Dunn, R. L., Sarma, A. V., Montie, J. E., & Cooney, K. A. (2007) · Cancer · doi:10.1002/cncr.22461 · Cited by 99
Aspirin use in relation to risk of prostate cancer.
Leitzmann, M. F., Stampfer, M. J., Ma, J., Chan, J. M., Colditz, G. A., Willett, W. C., & Giovannucci, E. L. (2002) · PubMed · Cited by 98
van Gils, C. H., Bostick, R. M., Stern, M. C., & Taylor, J. A. (2002) · PubMed · Cited by 98
ATM polymorphisms as risk factors for prostate cancer development
Angèle, S., Falconer, A., Edwards, S. M., Dörk, T., Bremer, M., Moullan, N., Chapot, B., Muir, K. R., Houlston, R. S., Norman, A. R., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602007 · Cited by 97
Benign Prostatic Hyperplasia and Prostate Cancer
Guess, H. A. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000782 · Cited by 96
Role of HPC2/ELAC2 in hereditary prostate cancer.
Wang, L., McDonnell, S. K., Elkins, D. A., Slager, S. L., Christensen, E., Marks, A. F., Cunningham, J. M., Peterson, B. J., Jacobsen, S. J., Cerhan, J. R., et al. (2001) · PubMed · Cited by 96
Medeiros, R., Vasconcelos, A., Costa, S., Pinto, D., Ferreira, P., Lobo, F., Morais, A., Oliveira, J., & Lopes, C. (2003) · The Prostate · doi:10.1002/pros.10348 · Cited by 91
Chen, C., Lewis, S. K., Voigt, L. F., Fitzpatrick, A. L., Plymate, S. R., & Weiss, N. S. (2004) · Cancer · doi:10.1002/cncr.20727 · Cited by 91
Hubbard, J. S., Rohrmann, S., Landis, P., Metter, E. J., Muller, D. C., Andres, R., Carter, H. B., & Platz, E. A. (2004) · Urology · doi:10.1016/j.urology.2003.09.060 · Cited by 91
The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer.
Febbo, P. G., Kantoff, P. W., Platz, E. A., Casey, D., Batter, S., Giovannucci, E. L., Hennekens, C. H., & Stampfer, M. J. (1999) · PubMed · Cited by 90
Chang, B., Zheng, S. L., Hawkins, G. A., Isaacs, S. D., Wiley, K. E., Turner, A. R., Carpten, J. D., Bleecker, E. R., Walsh, P. C., Trent, J. M., et al. (2002) · PubMed · Cited by 89
The association between vasectomy and prostate cancer: a systematic review of the literature
Bernal‐Delgado, E., Latour-Pérez, J., Pradas-Arnal, F., & Gómez-López, L. I. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00142-3 · Cited by 89
Rennert, H., Zeigler-Johnson, C. M., Addya, K., Finley, M. J., Walker, A. H., Spangler, E., Leonard, D. G. B., Wein, A. J., Malkowicz, S. B., & Rebbeck, T. R. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0637 · Cited by 87
SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis.
Ntais, C., Polycarpou, A., & Ioannidis, J. P. A. (2003) · PubMed · Cited by 87
Cicek, M. S., Conti, D. V., Curran, A. P., Neville, P. J., Paris, P. L., Casey, G., & Witte, J. S. (2003) · The Prostate · doi:10.1002/pros.10358 · Cited by 86
Chang, B., Zheng, S. L., Hawkins, G. A., Isaacs, S. D., Wiley, K. E., Turner, A. R., Carpten, J. D., Bleecker, E. R., Walsh, P. C., Trent, J. M., et al. (2002) · Human Genetics · doi:10.1007/s00439-001-0662-6 · Cited by 86
Gsur, A. (2002) · Carcinogenesis · doi:10.1093/carcin/23.10.1647 · Cited by 85
Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.
Ntais, C., Polycarpou, A., & Ioannidis, J. P. A. (2003) · PubMed · Cited by 85
Sexual Behavior and Evidence for an Infectious Cause of Prostate Cancer
Strickler, H. D., & Goedert, J. J. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000781 · Cited by 83
Hayes, V. M., Severi, G., Eggleton, S. A., Padilla, E. J. D., Southey, M. C., Sutherland, R. L., Hopper, J. L., & Giles, G. G. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0778 · Cited by 82
The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer.
Haiman, C. A., Stampfer, M. J., Giovannucci, E. L., Ma, J., Decalo, N. E., Kantoff, P. W., & Hunter, D. J. (2001) · PubMed · Cited by 81
Nam, R. K., Zhang, W., Trachtenberg, J., Jewett, M. A. S., Emami, M., Vesprini, D., Chu, W., Ho, M., Sweet, J., Evans, A., et al. (2003) · PubMed · Cited by 80
Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene
Maier, C., Haeusler, J., Herkommer, K., Vesovic, Z., Hoegel, J. J., Vogel, W., & Paiss, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602401 · Cited by 79
Proliferation and differentiation of prostatic stromal cells
Niu, Y., Xu, Y., Zhang, J., Bai, J., Yang, H., & Ma, T. (2001) · British Journal of Urology · doi:10.1046/j.1464-410x.2001.00103.x · Cited by 78
Occupation and Prostate Cancer Risk in Sweden
Sharma-Wagner, S., Chokkalingam, A. P., Malker, H., Stone, B. J., McLaughlin, J. K., & Hsing, A. W. (2000) · Journal of Occupational and Environmental Medicine · doi:10.1097/00043764-200005000-00010 · Cited by 75
Self-citationThe role of vitamin D in prostate cancer
Zhao, X.-Y., & Feldman, D. (2001) · Steroids · doi:10.1016/s0039-128x(00)00164-1 · Cited by 75
Genetic Variants of DNA Repair Genes and Prostate Cancer: A Population-Based Study
Ritchey, J. D., Huang, W., Chokkalingam, A. P., Gao, Y., Deng, J., Levine, P. H., Stanczyk, F. Z., & Hsing, A. W. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0809 · Cited by 75
Self-citationAndrogen receptor CAG polymorphism and prostate cancer risk
Mononen, N., Ikonen, T., Autio, V., Rökman, A., Matikainen, M. P., Tammela, T. L. J., Kallioniemi, O., Koivisto, P. A., & Schleutker, J. (2002) · Human Genetics · doi:10.1007/s00439-002-0776-5 · Cited by 74
Perspective: prostate cancer susceptibility genes.
Simard, J., Dumont, M., Soucy, P., & Labrie, F. (2002) · Endocrinology · doi:10.1210/endo.143.6.8890 · Cited by 74
Murata, M., Shiraishi, T., Fukutome, K., et al. (1998) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/28.11.657 · Cited by 74
Androgen receptor polymorphisms and the incidence of prostate cancer.
Chen, C., Lamharzi, N., Weiss, N. S., Etzioni, R., Dightman, D. A., Barnett, M. J., diTommaso, D., & Goodman, G. E. (2002) · PubMed · Cited by 74
5alpha-reductase 2 polymorphisms as risk factors in prostate cancer.
Soderstrom, T., Wadelius, M., Andersson, S., Johansson, J., Johansson, S., Granath, F. N., & Rane, A. (2002) · Pharmacogenetics · doi:10.1097/00008571-200206000-00006 · Cited by 71
Androgen Receptor Length Polymorphism Associated with Prostate Cancer Risk in Hispanic Men
Balic, I., GRAHAM, S. T., Troyer, D. A., Higgins, B., Pollock, B. H., Johnson‐Pais, T. L., Thompson, I. M., & Leach, R. J. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64364-9 · Cited by 70
Risk of Early-Onset Prostate Cancer in Relation to Germ Line Polymorphisms of the Vitamin D Receptor
Oakley-Girvan, I. A., Feldman, D., Eccleshall, T. R., Gallagher, R. P., Wu, A. H., Kolonel, L. N., Halpern, J., Balise, R. R., West, D. W., Paffenbarger, R. S., et al. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.1325.13.8 · Cited by 70
Miller, D. C., Zheng, S. L., Dunn, R. L., Sarma, A. V., Montie, J. E., Lange, E. M., Meyers, D. A., Xu, J., & Cooney, K. A. (2003) · PubMed · Cited by 68
A Gain of Function TGFB1 Polymorphism May Be Associated With Late Stage Prostate Cancer
Toland, A. E., Chan, J. M., Yuan, J., Balmain, A., & Ma, J. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.759.13.5 · Cited by 67
New Paraoxonase 1 Polymorphism I102V and the Risk of Prostate Cancer in Finnish Men
Marchesani, M., Hakkarainen, A., Tuomainen, T., Kaikkonen, J., Pukkala, ., Uimari, P., Seppälä, E. H., Matikainen, M. P., Kallioniemi, O., Schleutker, J., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.11.812 · Cited by 66
Mononen, N., Ikonen, T., Syrjäkoski, K., Matikainen, M., Schleutker, J., Tammela, T., Koivisto, P., & Kallioniemi, O. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1789 · Cited by 65
Beilin, J., Harewood, L., Frydenberg, M., Mameghan, H., Martyres, R., FARISH, S. J., Yue, C., Deam, D. R., Byron, K. A., & Zajac, J. D. (2001) · Cancer · Cited by 64
Germ-line alterations in MSR1 gene and prostate cancer risk.
Seppälä, E. H., Ikonen, T., Autio, V., Rökman, A., Mononen, N., Matikainen, M. P., Tammela, T. L. J., & Schleutker, J. (2003) · PubMed · Cited by 64
Polymorphisms in the CYP1A1 gene are associated with prostate cancer risk
Chang, B., Zheng, S. L., Isaacs, S. D., Turner, A. R., Hawkins, G. A., Wiley, K. E., Bleecker, E. R., Walsh, P. C., Meyers, D. A., Isaacs, W. B., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11249 · Cited by 62
Medical history, sexual, and maturational factors and prostate cancer risk
Lightfoot, N., Conlon, M., Kreiger, N., SASS-KORTSAK, A. M., Purdham, J. T., & Darlington, G. (2004) · Annals of Epidemiology · doi:10.1016/j.annepidem.2003.11.006 · Cited by 62
Association of V89L SRD5A2 Polymorphism With Prostate Cancer Development in a Japanese Population
LI, Z., Habuchi, T., Mitsumori, K., Kamoto, T., KINOSHITU, H., Segawa, T., Ogawa, O., & Kato, T. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000056152.57018.31 · Cited by 61
Camp, N. J., & Tavtigian, S. V. (2002) · The American Journal of Human Genetics · doi:10.1086/344516 · Cited by 61
Kantoff, P. W., Febbo, P. G., Giovannucci, E. L., Krithivas, K., Dahl, D. M., Chang, G. T. G., Hennekens, C. H., Brown, M., & Stampfer, M. J. (1997) · PubMed · Cited by 61
Dennis, L. K., Dawson, D. V., & Resnick, M. I. (2002) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500586 · Cited by 60
Medical History and Etiology of Prostate Cancer
Giovannucci, E. L. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000783 · Cited by 60
Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer.
Rosenblatt, K. A., Carter, J. J., Iwasaki, L., et al. (2003) · PubMed · Cited by 60
Does Physical Activity Play a Role in the Prevention of Prostate Cancer?
Lee, I.-M. M., Sesso, H. D., Chen, J. J., & Paffenbarger, R. S. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000778 · Cited by 58
Hormones and Prostate Cancer: Where Do We Go From Here?
Hsing, A. W. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1093 · Cited by 55
Self-citationMargiotti, K., Kim, E. S., Pearce, C. L., Spera, E., Novelli, G., & Reichardt, J. K. V. (2002) · The Prostate · doi:10.1002/pros.10134 · Cited by 54
Loukola, A., Chadha, M., Penn, S. G., Rank, D. R., Conti, D. V., Thompson, D. J., Cicek, M. S., Love, B., Bivolarevic, V., Yang, Q., et al. (2003) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201101 · Cited by 53
Association between hormonal genetic polymorphisms and early-onset prostate cancer
Forrest, M. S., Edwards, S. M., Houlston, R. S., Kote‐Jarai, Z., Key, T. J., Allen, N. E., Knowles, M. A., Turner, F., Ardern-Jones, A. T., Murkin, A., et al. (2005) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500785 · Cited by 53
Neuhausen, S. L., Slattery, M. L., Garner, C. P., Ding, Y. C., Hoffman, M. D., & Brothman, A. R. (2005) · The Prostate · doi:10.1002/pros.20216 · Cited by 53
Polymorphism of the insulin gene is associated with increased prostate cancer risk
Ho, G., Melman, A., Liu, S. M., Li, M., Yu, H., Negassa, A., Burk, R. D., Hsing, A. W., Ghavamian, R., & Chua, S. C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600747 · Cited by 52
Self-citationMadigan, M. P., Gao, Y.-T., Deng, J., Pfeiffer, R. M., Chang, B., Zheng, S. L., Meyers, D. A., Stanczyk, F. Z., Xu, J., & Hsing, A. W. (2003) · International Journal of Cancer · doi:10.1002/ijc.11378 · Cited by 50
Self-citationPolymorphic repeats in the androgen receptor gene in high‐risk sibships
Miller, E. A., Stanford, J. L., Hsu, L., Noonan, E. A., & Ostrander, E. A. (2001) · The Prostate · doi:10.1002/pros.1098 · Cited by 49
Nutritional Factors in Human Cancers
Giovannucci, E. L. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-3230-6_3 · Cited by 46
Suzuki, K., Matsui, H., Nakazato, H., Koike, H., Okugi, H., Hasumi, M., Ohtake, N., Nakata, S., Takei, T., Hatori, M., et al. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00182-4 · Cited by 43
Paltoo, D. N., Woodson, K. G., Taylor, P. R., Albanes, D., Virtamo, J. R. K., & Tangrea, J. A. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00617-1 · Cited by 41
Pearce, C. L., Makridakis, N. M., Ross, R. K., Pike, M. C., Kolonel, L. N., Henderson, B. E., & Reichardt, J. K. V. (2002) · PubMed · Cited by 40
Margiotti, K., Sangiuolo, F. C., Luca, A. D., Froio, F., Pearce, C. L., Ricci-Barbini, V., Micali, F., Bonafè, M., Franceschi, C., Dallapiccola, B., et al. (2000) · Disease Markers · doi:10.1155/2000/683607 · Cited by 38
Androgen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population
dos Santos, M. L., Sarkis, A. S., Nishimoto, I. N., & Nagai, M. A. (2003) · Cancer Detection and Prevention · doi:10.1016/s0361-090x(03)00106-5 · Cited by 36
Fatty Acids and Gene Expression Related to Inflammation
Calder, P. C. (2002) · KARGER eBooks · doi:10.1159/000067510 · Cited by 33
Androgen receptor gene polymorphism and prostate cancer in Taiwan.
Huang, S., Chou, Y., Chang, W. W., Wu, M., Yu, C., Wu, T. T., Lee, Y.-H., Huang, J., Wu, W., & Huang, C. (2003) · PubMed · Cited by 29
Pak, R. W., Lanteri, V. J., Scheuch, J., & Sawczuk, I. S. (2002) · Integrative Cancer Therapies · doi:10.1177/1534735402238186 · Cited by 28
Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer
Chang, B., Zheng, S. L., Isaacs, S. D., et al. (2003) · The Prostate · doi:10.1002/pros.10225 · Cited by 27
Polymorphic markers in the 5α‐reductase type II gene and the incidence of prostate cancer
Lamharzi, N., Johnson, M. M., Goodman, G. E., Etzioni, R., Weiss, N. S., Dightman, D. A., Barnett, M. J., diTommaso, D., & Chen, C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11126 · Cited by 26
Macrophage Scavenger Receptor 1 999C>T (R293X) Mutation and Risk of Prostate Cancer
Hope, Q., Bullock, S. L., Evans, C., Meitz-Hopkins, J. C., Hamel, N., Edwards, S. M., Severi, G., Dearnaley, D. P., Jhavar, S. G., Southgate, C., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0202 · Cited by 21
CYP17 gene promoter allelic variant is not associated with prostate cancer
Lin, C., Wu, H., Chen, W., Chen, H.-Y., & Tsai, F. (2003) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/s1078-1439(02)00276-4 · Cited by 15
Cited by
Obesity, metabolic syndrome, and prostate cancer
Hsing, A. W., Sakoda, L. C., & Chua, S. C. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.3.843s · Cited by 344
Self-citationRole of chemokines and chemokine receptors in prostate cancer development and progression.
Singh, R. K., Sudhakar, A., & Lokeshwar, B. L. (2010) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000030 · Cited by 45
Metadata
- Authors
- Hsing, A.
- Venue
- Frontiers in Bioscience
- Publisher
- IMR Press
- Published
- 2006
- Volume
- 11
- Issue
- 1
- Pages
- 1388
- ISSN
- 1093-4715 (ISSN-L)
- 1093-9946
- DOI
- 10.2741/1891
- OpenAlex
- W2129631700
- Cited by
- 447
- References
- 168
- FWCI
- 20.66
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.